Hospital del Mar leads clinical trial of a new tool for detecting the sentinel lymph node in prostate cancer

Hospital del Mar-IMIM is leading an international clinical trial to evaluate the performance and suitability of new equipment for locating the sentinel lymph node in prostate cancer patients. The new tool is a flexible, miniaturized probe, which should improve the detection of a marker (a radioactive molecule) injected into the patient to locate the first node the tumour drains to. The technology SENSEI^®, has been developed by the UK company Lightpoint Medical with the support of the Hospital del Mar Urology Service.

Read more sobre "Hospital del Mar leads clinical trial of a new tool for detecting the sentinel lymph node in prostate cancer"